What is the primary action of Verapamil in cardiac treatment?

What is the primary action of Verapamil in cardiac treatment?

• A. Increases heart rate
• B. Blocks calcium ion influx through slow calcium channels
• C. Enhances electrical impulse conduction through the AV node
• D. Stimulates myocardial contraction

Answer: (B)

Verapamil primarily functions by blocking calcium ion influx through slow calcium channels. This mechanism is crucial in cardiac treatment, as it effectively reduces the amount of calcium that enters cardiac and smooth muscle cells during depolarization. Calcium plays an essential role in the contraction of the heart muscle; by inhibiting its entry, Verapamil leads to decreased myocardial contractility (negative inotropic effect) and facilitates relaxation of the heart muscle. Additionally, this action slows down conduction through the atrioventricular (AV) node, which is particularly beneficial for managing certain types of arrhythmias. The reduction in calcium influx also results in decreased heart rate, as it helps to control the conduction of electrical impulses in the heart, particularly under conditions of abnormal electrical activity. In the context of the other choices provided: increasing heart rate, enhancing electrical impulse conduction through the AV node, and stimulating myocardial contraction do not align with the primary pharmacological effects of Verapamil. Instead, its primary role as a calcium channel blocker is critical for its therapeutic use in treating conditions such as hypertension, angina, and certain arrhythmias.

Verapamil primarily functions by blocking calcium ion influx through slow calcium channels. This mechanism is crucial in cardiac treatment, as it effectively reduces the amount of calcium that enters cardiac and smooth muscle cells during depolarization. Calcium plays an essential role in the contraction of the heart muscle; by inhibiting its entry, Verapamil leads to decreased myocardial contractility (negative inotropic effect) and facilitates relaxation of the heart muscle.

Additionally, this action slows down conduction through the atrioventricular (AV) node, which is particularly beneficial for managing certain types of arrhythmias. The reduction in calcium influx also results in decreased heart rate, as it helps to control the conduction of electrical impulses in the heart, particularly under conditions of abnormal electrical activity.

In the context of the other choices provided: increasing heart rate, enhancing electrical impulse conduction through the AV node, and stimulating myocardial contraction do not align with the primary pharmacological effects of Verapamil. Instead, its primary role as a calcium channel blocker is critical for its therapeutic use in treating conditions such as hypertension, angina, and certain arrhythmias.